<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1990-11-01" modified="2020-10-07" version="229">
<accession>P19235</accession>
<accession>B2RCG4</accession>
<accession>Q15443</accession>
<accession>Q2M205</accession>
<name>EPOR_HUMAN</name>
<protein>
<recommendedName>
<fullName>Erythropoietin receptor</fullName>
<shortName>EPO-R</shortName>
</recommendedName>
</protein>
<gene>
<name type="primary">EPOR</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="Blood" volume="76" first="24" last="30">
<title>The gene for the human erythropoietin receptor: analysis of the coding sequence and assignment to chromosome 19p.</title>
<authorList>
<person name="Winkelmann J.C."/>
<person name="Penny L.A."/>
<person name="Deaven L.L."/>
<person name="Forget B.G."/>
<person name="Jenkins R.B."/>
</authorList>
<dbReference type="PubMed" id="2163695"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1990" name="Blood" volume="76" first="31" last="35">
<title>Human erythropoietin receptor: cloning, expression, and biologic characterization.</title>
<authorList>
<person name="Jones S.S."/>
<person name="D'Andrea A.D."/>
<person name="Haines L.L."/>
<person name="Wong G.G."/>
</authorList>
<dbReference type="PubMed" id="2163696"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM EPOR-F)</scope>
<source>
<tissue>Erythroleukemia</tissue>
<tissue>Fetal liver</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1991" name="Blood" volume="78" first="2548" last="2556">
<title>Cloning of the human erythropoietin receptor gene.</title>
<authorList>
<person name="Noguchi C.T."/>
<person name="Bae K.S."/>
<person name="Chin K."/>
<person name="Wada Y."/>
<person name="Schechter A.N."/>
<person name="Hankins W.D."/>
</authorList>
<dbReference type="PubMed" id="1668606"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1991" name="Exp. Hematol." volume="19" first="973" last="977">
<title>The erythropoietin receptor gene: cloning and identification of multiple transcripts in an erythroid cell line OCIM1.</title>
<authorList>
<person name="Ehrenman K."/>
<person name="St John T."/>
</authorList>
<dbReference type="PubMed" id="1654273"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM EPOR-F)</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1992" name="Science" volume="257" first="1138" last="1141">
<title>A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells.</title>
<authorList>
<person name="Nakamura Y."/>
<person name="Komatsu N."/>
<person name="Nakauchi H."/>
</authorList>
<dbReference type="PubMed" id="1324524"/>
<dbReference type="DOI" id="10.1126/science.257.5073.1138"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS EPOR-F; EPOR-S AND EPOR-T)</scope>
<source>
<tissue>Bone marrow</tissue>
<tissue>Megakaryoblast</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM EPOR-F)</scope>
<source>
<tissue>Caudate nucleus</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM EPOR-F)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1991" name="Blood" volume="78" first="2557" last="2563">
<title>Cloning of the gene encoding the human erythropoietin receptor.</title>
<authorList>
<person name="Maouche L."/>
<person name="Tournamille C."/>
<person name="Hattab C."/>
<person name="Boffa G."/>
<person name="Cartron J.-P."/>
<person name="Chretien S."/>
</authorList>
<dbReference type="PubMed" id="1668607"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-96</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1991" name="Genomics" volume="11" first="974" last="980">
<title>Genomic organization of the human erythropoietin receptor gene.</title>
<authorList>
<person name="Penny L.A."/>
<person name="Forget B.G."/>
</authorList>
<dbReference type="PubMed" id="1664413"/>
<dbReference type="DOI" id="10.1016/0888-7543(91)90022-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-17</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1991" name="Gene" volume="106" first="283" last="284">
<title>Isolation of a cDNA encoding a potential soluble receptor for human erythropoietin.</title>
<authorList>
<person name="Todokoro K."/>
<person name="Kuramochi S."/>
<person name="Nagasawa T."/>
<person name="Abe T."/>
<person name="Ikawa Y."/>
</authorList>
<dbReference type="PubMed" id="1657727"/>
<dbReference type="DOI" id="10.1016/0378-1119(91)90213-u"/>
</citation>
<scope>PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (EPOR-S)</scope>
<source>
<tissue>Erythroid cell</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="Blood" volume="99" first="102" last="110">
<title>Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation.</title>
<authorList>
<person name="Kirito K."/>
<person name="Nakajima K."/>
<person name="Watanabe T."/>
<person name="Uchida M."/>
<person name="Tanaka M."/>
<person name="Ozawa K."/>
<person name="Komatsu N."/>
</authorList>
<dbReference type="PubMed" id="11756159"/>
<dbReference type="DOI" id="10.1182/blood.v99.1.102"/>
</citation>
<scope>STAT1/STAT3 ACTIVATION</scope>
<scope>MUTAGENESIS OF TYR-456 AND TYR-468</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="5631" last="5635">
<title>Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways.</title>
<authorList>
<person name="Tauchi T."/>
<person name="Feng G.-S."/>
<person name="Shen R."/>
<person name="Hoatlin M."/>
<person name="Bagby G.C. Jr."/>
<person name="Kabat D."/>
<person name="Lu L."/>
<person name="Broxmeyer H.E."/>
</authorList>
<dbReference type="PubMed" id="7534299"/>
<dbReference type="DOI" id="10.1074/jbc.270.10.5631"/>
</citation>
<scope>INTERACTION WITH PTPN11</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="14045" last="14054">
<title>Identification of a critical ligand binding determinant of the human erythropoietin receptor. Evidence for common ligand binding motifs in the cytokine receptor family.</title>
<authorList>
<person name="Middleton S.A."/>
<person name="Johnson D.L."/>
<person name="Jin R."/>
<person name="McMahon F.J."/>
<person name="Collins A."/>
<person name="Tullai J."/>
<person name="Gruninger R.H."/>
<person name="Jolliffe L.K."/>
<person name="Mulcahy L.S."/>
</authorList>
<dbReference type="PubMed" id="8662939"/>
<dbReference type="DOI" id="10.1074/jbc.271.24.14045"/>
</citation>
<scope>LIGAND-BINDING SITE</scope>
<scope>MUTAGENESIS OF THR-114; SER-115; SER-116; PHE-117; VAL-118; LEU-120; GLU-121; ARG-165; MET-174; SER-176; HIS-177 AND ARG-179</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2001" name="Eur. J. Haematol." volume="67" first="88" last="93">
<title>Increased cell surface expression of C-terminal truncated erythropoietin receptors in polycythemia.</title>
<authorList>
<person name="Motohashi T."/>
<person name="Nakamura Y."/>
<person name="Osawa M."/>
<person name="Hiroyama T."/>
<person name="Iwama A."/>
<person name="Shibuya A."/>
<person name="Nakauchi H."/>
</authorList>
<dbReference type="PubMed" id="11722595"/>
<dbReference type="DOI" id="10.1034/j.1600-0609.2001.t01-1-00446.x"/>
</citation>
<scope>SUBCELLULAR LOCATION (ISOFORM EPOR-S)</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2002" name="Eur. J. Biochem." volume="269" first="2516" last="2526">
<title>A new high affinity binding site for suppressor of cytokine signaling-3 on the erythropoietin receptor.</title>
<authorList>
<person name="Hoertner M."/>
<person name="Nielsch U."/>
<person name="Mayr L.M."/>
<person name="Heinrich P.C."/>
<person name="Haan S."/>
</authorList>
<dbReference type="PubMed" id="12027890"/>
<dbReference type="DOI" id="10.1046/j.1432-1033.2002.02916.x"/>
</citation>
<scope>INTERACTION WITH SOCS3</scope>
<scope>MUTAGENESIS OF TYR-454 AND TYR-456</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="26851" last="26861">
<title>Erythropoietin receptors associate with a ubiquitin ligase, p33RUL, and require its activity for erythropoietin-induced proliferation.</title>
<authorList>
<person name="Friedman A.D."/>
<person name="Nimbalkar D."/>
<person name="Quelle F.W."/>
</authorList>
<dbReference type="PubMed" id="12746455"/>
<dbReference type="DOI" id="10.1074/jbc.m210039200"/>
</citation>
<scope>INTERACTION WITH NOSIP</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1999" name="Leukemia" volume="13" first="760" last="767">
<title>APS, an adaptor protein containing pleckstrin homology (PH) and Src homology-2 (SH2) domains inhibits the JAK-STAT pathway in collaboration with c-Cbl.</title>
<authorList>
<person name="Wakioka T."/>
<person name="Sasaki A."/>
<person name="Mitsui K."/>
<person name="Yokouchi M."/>
<person name="Inoue A."/>
<person name="Komiya S."/>
<person name="Yoshimura A."/>
</authorList>
<dbReference type="PubMed" id="10374881"/>
<dbReference type="DOI" id="10.1038/sj.leu.2401397"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH APS</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="9139" last="9147">
<title>Cloning and characterization of a family of proteins associated with Mpl.</title>
<authorList>
<person name="Meunier C.F."/>
<person name="Bordereaux D."/>
<person name="Porteu F."/>
<person name="Gisselbrecht S."/>
<person name="Chretien S."/>
<person name="Courtois G."/>
</authorList>
<dbReference type="PubMed" id="11784712"/>
<dbReference type="DOI" id="10.1074/jbc.m105970200"/>
</citation>
<scope>INTERACTION WITH ATXN2L</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2014" name="J. Exp. Med." volume="211" first="1715" last="1722">
<title>RHEX, a novel regulator of human erythroid progenitor cell expansion and erythroblast development.</title>
<authorList>
<person name="Verma R."/>
<person name="Su S."/>
<person name="McCrann D.J."/>
<person name="Green J.M."/>
<person name="Leu K."/>
<person name="Young P.R."/>
<person name="Schatz P.J."/>
<person name="Silva J.C."/>
<person name="Stokes M.P."/>
<person name="Wojchowski D.M."/>
</authorList>
<dbReference type="PubMed" id="25092874"/>
<dbReference type="DOI" id="10.1084/jem.20130624"/>
</citation>
<scope>INTERACTION WITH RHEX</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1996" name="Science" volume="273" first="464" last="471">
<title>Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A.</title>
<authorList>
<person name="Livnah O."/>
<person name="Stura E.A."/>
<person name="Johnson D.L."/>
<person name="Middleton S.A."/>
<person name="Mulcahy L.S."/>
<person name="Wrighton N.C."/>
<person name="Dower W.J."/>
<person name="Jolliffe L.K."/>
<person name="Wilson I.A."/>
</authorList>
<dbReference type="PubMed" id="8662530"/>
<dbReference type="DOI" id="10.1126/science.273.5274.464"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 34-244</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1998" name="Nat. Struct. Biol." volume="5" first="993" last="1004">
<title>An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation.</title>
<authorList>
<person name="Livnah O."/>
<person name="Johnson D.L."/>
<person name="Stura E.A."/>
<person name="Farrell F.X."/>
<person name="Barbone F.P."/>
<person name="You Y."/>
<person name="Liu K.D."/>
<person name="Goldsmith M.A."/>
<person name="He W."/>
<person name="Krause C.D."/>
<person name="Pestka S."/>
<person name="Jolliffe L.K."/>
<person name="Wilson I.A."/>
</authorList>
<dbReference type="PubMed" id="9808045"/>
<dbReference type="DOI" id="10.1038/2965"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 34-244</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1998" name="Nature" volume="395" first="511" last="516">
<title>Efficiency of signalling through cytokine receptors depends critically on receptor orientation.</title>
<authorList>
<person name="Syed R.S."/>
<person name="Reid S.W."/>
<person name="Li C."/>
<person name="Cheetham J.C."/>
<person name="Aoki K.H."/>
<person name="Liu B."/>
<person name="Zhan H."/>
<person name="Osslund T.D."/>
<person name="Chirino A.J."/>
<person name="Zhang J."/>
<person name="Finer-Moore J."/>
<person name="Elliott S."/>
<person name="Sitney K."/>
<person name="Katz B.A."/>
<person name="Matthews D.J."/>
<person name="Wendoloski J.J."/>
<person name="Egrie J."/>
<person name="Stroud R.M."/>
</authorList>
<dbReference type="PubMed" id="9774108"/>
<dbReference type="DOI" id="10.1038/26773"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 32-244 IN COMPLEX WITH EPO</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1999" name="Protein Eng." volume="12" first="505" last="513">
<title>Engineering a soluble extracellular erythropoietin receptor (EPObp) in Pichia pastoris to eliminate microheterogeneity, and its complex with erythropoietin.</title>
<authorList>
<person name="Zhan H."/>
<person name="Liu B."/>
<person name="Reid S.W."/>
<person name="Aoki K.H."/>
<person name="Li C."/>
<person name="Syed R.S."/>
<person name="Karkaria C."/>
<person name="Koe G."/>
<person name="Sitney K."/>
<person name="Hayenga K."/>
<person name="Mistry F."/>
<person name="Savel L."/>
<person name="Dreyer M."/>
<person name="Katz B.A."/>
<person name="Schreurs J."/>
<person name="Matthews D.J."/>
<person name="Cheetham J.C."/>
<person name="Egrie J."/>
<person name="Giebel L.B."/>
<person name="Stroud R.M."/>
</authorList>
<dbReference type="PubMed" id="10388848"/>
<dbReference type="DOI" id="10.1093/protein/12.6.505"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 22-249 IN COMPLEX WITH EPO</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1999" name="Science" volume="283" first="987" last="990">
<title>Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation.</title>
<authorList>
<person name="Livnah O."/>
<person name="Stura E.A."/>
<person name="Middleton S.A."/>
<person name="Johnson D.L."/>
<person name="Jolliffe L.K."/>
<person name="Wilson I.A."/>
</authorList>
<dbReference type="PubMed" id="9974392"/>
<dbReference type="DOI" id="10.1126/science.283.5404.987"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 34-246</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1993" name="Proc. Natl. Acad. Sci. U.S.A." volume="90" first="4495" last="4499">
<title>Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis.</title>
<authorList>
<person name="de la Chapelle A."/>
<person name="Traskelin A.-L."/>
<person name="Juvonen E."/>
</authorList>
<dbReference type="PubMed" id="8506290"/>
<dbReference type="DOI" id="10.1073/pnas.90.10.4495"/>
</citation>
<scope>INVOLVEMENT IN ECYT1</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1994" name="Exp. Hematol." volume="22" first="447" last="453">
<title>Mutation in the negative regulatory element of the erythropoietin receptor gene in a case of sporadic primary polycythemia.</title>
<authorList>
<person name="Sokol L."/>
<person name="Prchal J.F."/>
<person name="D'Andrea A."/>
<person name="Rado T.A."/>
<person name="Prchal J.T."/>
</authorList>
<dbReference type="PubMed" id="8174675"/>
</citation>
<scope>VARIANT SER-488</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1996" name="Blood" volume="87" first="1502" last="1511">
<title>Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies.</title>
<authorList>
<person name="Le Couedic J.-P."/>
<person name="Mitjavila M.-T."/>
<person name="Villeval J.-L."/>
<person name="Feger F."/>
<person name="Gobert S."/>
<person name="Mayeux P."/>
<person name="Casadevall N."/>
<person name="Vainchenker W."/>
</authorList>
<dbReference type="PubMed" id="8608241"/>
</citation>
<scope>VARIANT ECYT1 SER-487</scope>
<scope>VARIANT ERYTHROLEUKEMIA SER-487</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2016" name="Nature" volume="536" first="285" last="291">
<title>Analysis of protein-coding genetic variation in 60,706 humans.</title>
<authorList>
<consortium name="Exome Aggregation Consortium"/>
<person name="Lek M."/>
<person name="Karczewski K.J."/>
<person name="Minikel E.V."/>
<person name="Samocha K.E."/>
<person name="Banks E."/>
<person name="Fennell T."/>
<person name="O'Donnell-Luria A.H."/>
<person name="Ware J.S."/>
<person name="Hill A.J."/>
<person name="Cummings B.B."/>
<person name="Tukiainen T."/>
<person name="Birnbaum D.P."/>
<person name="Kosmicki J.A."/>
<person name="Duncan L.E."/>
<person name="Estrada K."/>
<person name="Zhao F."/>
<person name="Zou J."/>
<person name="Pierce-Hoffman E."/>
<person name="Berghout J."/>
<person name="Cooper D.N."/>
<person name="Deflaux N."/>
<person name="DePristo M."/>
<person name="Do R."/>
<person name="Flannick J."/>
<person name="Fromer M."/>
<person name="Gauthier L."/>
<person name="Goldstein J."/>
<person name="Gupta N."/>
<person name="Howrigan D."/>
<person name="Kiezun A."/>
<person name="Kurki M.I."/>
<person name="Moonshine A.L."/>
<person name="Natarajan P."/>
<person name="Orozco L."/>
<person name="Peloso G.M."/>
<person name="Poplin R."/>
<person name="Rivas M.A."/>
<person name="Ruano-Rubio V."/>
<person name="Rose S.A."/>
<person name="Ruderfer D.M."/>
<person name="Shakir K."/>
<person name="Stenson P.D."/>
<person name="Stevens C."/>
<person name="Thomas B.P."/>
<person name="Tiao G."/>
<person name="Tusie-Luna M.T."/>
<person name="Weisburd B."/>
<person name="Won H.H."/>
<person name="Yu D."/>
<person name="Altshuler D.M."/>
<person name="Ardissino D."/>
<person name="Boehnke M."/>
<person name="Danesh J."/>
<person name="Donnelly S."/>
<person name="Elosua R."/>
<person name="Florez J.C."/>
<person name="Gabriel S.B."/>
<person name="Getz G."/>
<person name="Glatt S.J."/>
<person name="Hultman C.M."/>
<person name="Kathiresan S."/>
<person name="Laakso M."/>
<person name="McCarroll S."/>
<person name="McCarthy M.I."/>
<person name="McGovern D."/>
<person name="McPherson R."/>
<person name="Neale B.M."/>
<person name="Palotie A."/>
<person name="Purcell S.M."/>
<person name="Saleheen D."/>
<person name="Scharf J.M."/>
<person name="Sklar P."/>
<person name="Sullivan P.F."/>
<person name="Tuomilehto J."/>
<person name="Tsuang M.T."/>
<person name="Watkins H.C."/>
<person name="Wilson J.G."/>
<person name="Daly M.J."/>
<person name="MacArthur D.G."/>
</authorList>
<dbReference type="PubMed" id="27535533"/>
<dbReference type="DOI" id="10.1038/nature19057"/>
</citation>
<scope>VARIANT SER-488</scope>
</reference>
<comment type="function">
<text>Receptor for erythropoietin. Mediates erythropoietin-induced erythroblast proliferation and differentiation. Upon EPO stimulation, EPOR dimerizes triggering the JAK2/STAT5 signaling cascade. In some cell types, can also activate STAT1 and STAT3. May also activate the LYN tyrosine kinase.</text>
</comment>
<comment type="function">
<text>Isoform EPOR-T acts as a dominant-negative receptor of EPOR-mediated signaling.</text>
</comment>
<comment type="subunit">
<text evidence="9 13 14 17 18 19 20 22 27">Forms homodimers on EPO stimulation. The tyrosine-phosphorylated form interacts with several SH2 domain-containing proteins including LYN (By similarity), the adapter protein APS, PTPN6 (By similarity), PTPN11, JAK2, PI3 kinases, STAT5A/B, SOCS3, CRKL (By similarity). Interacts with INPP5D/SHIP1 (By similarity). The N-terminal SH2 domain of PTPN6 binds Tyr-454 and inhibits signaling through dephosphorylation of JAK2 (By similarity). APS binding also inhibits the JAK-STAT signaling. Binding to PTPN11, preferentially through the N-terminal SH2 domain, promotes mitogenesis and phosphorylation of PTPN11 (By similarity). Binding of JAK2 (through its N-terminal) promotes cell-surface expression (By similarity). Interacts with RHEX; this interaction occurs in a erythropoietin (EPO)-dependent manner (PubMed:25092874). Interaction with the ubiquitin ligase NOSIP mediates EPO-induced cell proliferation. Interacts with ATXN2L.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-617321">
<id>P19235</id>
</interactant>
<interactant intactId="EBI-948363">
<id>Q8WWM7</id>
<label>ATXN2L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-617321">
<id>P19235</id>
</interactant>
<interactant intactId="EBI-1027362">
<id>P01588</id>
<label>EPO</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-617321">
<id>P19235</id>
</interactant>
<interactant intactId="EBI-11508463">
<id>PRO_0000008401</id>
<label>EPO</label>
<dbReference type="UniProtKB" id="P01588"/>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-617321">
<id>P19235</id>
</interactant>
<interactant intactId="EBI-617321">
<id>P19235</id>
<label>EPOR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-617321">
<id>P19235</id>
</interactant>
<interactant intactId="EBI-617403">
<id>P16885</id>
<label>PLCG2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-617321">
<id>P19235</id>
</interactant>
<interactant intactId="EBI-968788">
<id>P18031</id>
<label>PTPN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-617321">
<id>P19235</id>
</interactant>
<interactant intactId="EBI-78260">
<id>P29350</id>
<label>PTPN6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-617321">
<id>P19235</id>
</interactant>
<interactant intactId="EBI-617737">
<id>O14508</id>
<label>SOCS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-617321">
<id>P19235</id>
</interactant>
<interactant intactId="EBI-617489">
<id>Q62225</id>
<label>Cish</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform EPOR-S</molecule>
<subcellularLocation>
<location evidence="15">Secreted</location>
</subcellularLocation>
<text>Secreted and located to the cell surface.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P19235-1</id>
<name>EPOR-F</name>
<name>Full-length form</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P19235-2</id>
<name>EPOR-S</name>
<name>Soluble form</name>
<sequence type="described" ref="VSP_009508 VSP_009509"/>
</isoform>
<isoform>
<id>P19235-3</id>
<name>EPOR-T</name>
<name>Truncated form</name>
<sequence type="described" ref="VSP_009510 VSP_009511"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Erythroid cells and erythroid progenitor cells. Isoform EPOR-F is the most abundant form in EPO-dependent erythroleukemia cells and in late-stage erythroid progenitors. Isoform EPOR-S and isoform EPOR-T are the predominant forms in bone marrow. Isoform EPOR-T is the most abundant from in early-stage erythroid progenitor cells.</text>
</comment>
<comment type="domain">
<text>The WSXWS motif appears to be necessary for proper protein folding and thereby efficient intracellular transport and cell-surface receptor binding.</text>
</comment>
<comment type="domain">
<text>The box 1 motif is required for JAK interaction and/or activation.</text>
</comment>
<comment type="domain">
<text>Contains 1 copy of a cytoplasmic motif that is referred to as the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is involved in modulation of cellular responses. The phosphorylated ITIM motif can bind the SH2 domain of several SH2-containing phosphatases.</text>
</comment>
<comment type="PTM">
<text evidence="13">On EPO stimulation, phosphorylated on C-terminal tyrosine residues by JAK2. The phosphotyrosine motifs are also recruitment sites for several SH2-containing proteins and adapter proteins which mediate cell proliferation. Phosphorylation on Tyr-454 is required for PTPN6 interaction, Tyr-426 for PTPN11. Tyr-426 is also required for SOCS3 binding, but Tyr-454/Tyr-456 motif is the preferred binding site.</text>
</comment>
<comment type="PTM">
<text evidence="9">Ubiquitination at Lys-281 mediates receptor internalization, whereas ubiquitination at Lys-453 promotes trafficking of activated receptors to the lysosomes for degradation (By similarity). Ubiquitinated by NOSIP; appears to be either multi-monoubiquitinated or polyubiquitinated. Ubiquitination mediates proliferation and survival of EPO-dependent cells.</text>
</comment>
<comment type="disease" evidence="24 25">
<disease id="DI-00479">
<name>Erythrocytosis, familial, 1</name>
<acronym>ECYT1</acronym>
<description>An autosomal dominant disorder characterized by elevated hemoglobin and hematocrit, hypersensitivity of erythroid progenitors to erythropoietin, erythropoietin low serum levels, and no increase in platelets nor leukocytes. It has a relatively benign course and does not progress to leukemia.</description>
<dbReference type="MIM" id="133100"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="29">Belongs to the type I cytokine receptor family. Type 1 subfamily.</text>
</comment>
<dbReference type="EMBL" id="M60459">
<property type="protein sequence ID" value="AAA52403.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S45332">
<property type="protein sequence ID" value="AAB23271.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M34986">
<property type="protein sequence ID" value="AAA52401.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK315097">
<property type="protein sequence ID" value="BAG37561.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471106">
<property type="protein sequence ID" value="EAW84205.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC112153">
<property type="protein sequence ID" value="AAI12154.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M76595">
<property type="protein sequence ID" value="AAA52393.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M77244">
<property type="protein sequence ID" value="AAA52392.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X57282">
<property type="protein sequence ID" value="CAA40550.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12260.1">
<molecule id="P19235-1"/>
</dbReference>
<dbReference type="PIR" id="A43799">
<property type="entry name" value="ZUHUR"/>
</dbReference>
<dbReference type="PIR" id="I38208">
<property type="entry name" value="I38208"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000112.1">
<molecule id="P19235-1"/>
<property type="nucleotide sequence ID" value="NM_000121.3"/>
</dbReference>
<dbReference type="PDB" id="1CN4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=25-249"/>
</dbReference>
<dbReference type="PDB" id="1EBA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=34-248"/>
</dbReference>
<dbReference type="PDB" id="1EBP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=34-244"/>
</dbReference>
<dbReference type="PDB" id="1EER">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="B/C=27-250"/>
</dbReference>
<dbReference type="PDB" id="1ERN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=34-246"/>
</dbReference>
<dbReference type="PDB" id="2JIX">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="B/C/E=25-249"/>
</dbReference>
<dbReference type="PDB" id="2MV6">
<property type="method" value="NMR"/>
<property type="chains" value="A=237-284"/>
</dbReference>
<dbReference type="PDB" id="4Y5V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="C/F/I=32-249"/>
</dbReference>
<dbReference type="PDB" id="4Y5X">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.15"/>
<property type="chains" value="C/F/I/L=32-249"/>
</dbReference>
<dbReference type="PDB" id="4Y5Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="C/F=32-249"/>
</dbReference>
<dbReference type="PDB" id="6E2Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="M/N/O/P=273-338"/>
</dbReference>
<dbReference type="PDB" id="6MOE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.09"/>
<property type="chains" value="C/D=32-249"/>
</dbReference>
<dbReference type="PDB" id="6MOF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.89"/>
<property type="chains" value="B=32-249"/>
</dbReference>
<dbReference type="PDB" id="6MOH">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="C/D=32-249"/>
</dbReference>
<dbReference type="PDB" id="6MOI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.06"/>
<property type="chains" value="B=32-249"/>
</dbReference>
<dbReference type="PDB" id="6MOJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.43"/>
<property type="chains" value="B=32-249"/>
</dbReference>
<dbReference type="PDB" id="6MOK">
<property type="method" value="X-ray"/>
<property type="resolution" value="5.10"/>
<property type="chains" value="B=32-249"/>
</dbReference>
<dbReference type="PDB" id="6MOL">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.16"/>
<property type="chains" value="B/C=32-249"/>
</dbReference>
<dbReference type="PDBsum" id="1CN4"/>
<dbReference type="PDBsum" id="1EBA"/>
<dbReference type="PDBsum" id="1EBP"/>
<dbReference type="PDBsum" id="1EER"/>
<dbReference type="PDBsum" id="1ERN"/>
<dbReference type="PDBsum" id="2JIX"/>
<dbReference type="PDBsum" id="2MV6"/>
<dbReference type="PDBsum" id="4Y5V"/>
<dbReference type="PDBsum" id="4Y5X"/>
<dbReference type="PDBsum" id="4Y5Y"/>
<dbReference type="PDBsum" id="6E2Q"/>
<dbReference type="PDBsum" id="6MOE"/>
<dbReference type="PDBsum" id="6MOF"/>
<dbReference type="PDBsum" id="6MOH"/>
<dbReference type="PDBsum" id="6MOI"/>
<dbReference type="PDBsum" id="6MOJ"/>
<dbReference type="PDBsum" id="6MOK"/>
<dbReference type="PDBsum" id="6MOL"/>
<dbReference type="BMRB" id="P19235"/>
<dbReference type="SMR" id="P19235"/>
<dbReference type="BioGRID" id="108371">
<property type="interactions" value="34"/>
</dbReference>
<dbReference type="CORUM" id="P19235"/>
<dbReference type="DIP" id="DIP-5732N"/>
<dbReference type="ELM" id="P19235"/>
<dbReference type="IntAct" id="P19235">
<property type="interactions" value="21"/>
</dbReference>
<dbReference type="MINT" id="P19235"/>
<dbReference type="STRING" id="9606.ENSP00000222139"/>
<dbReference type="BindingDB" id="P19235"/>
<dbReference type="ChEMBL" id="CHEMBL1817"/>
<dbReference type="DrugBank" id="DB00012">
<property type="generic name" value="Darbepoetin alfa"/>
</dbReference>
<dbReference type="DrugBank" id="DB07637">
<property type="generic name" value="Dibromotyrosine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00016">
<property type="generic name" value="Erythropoietin"/>
</dbReference>
<dbReference type="DrugBank" id="DB09107">
<property type="generic name" value="Methoxy polyethylene glycol-epoetin beta"/>
</dbReference>
<dbReference type="DrugBank" id="DB08894">
<property type="generic name" value="Peginesatide"/>
</dbReference>
<dbReference type="DrugCentral" id="P19235"/>
<dbReference type="GuidetoPHARMACOLOGY" id="1718"/>
<dbReference type="GlyGen" id="P19235">
<property type="glycosylation" value="1 site"/>
</dbReference>
<dbReference type="iPTMnet" id="P19235"/>
<dbReference type="PhosphoSitePlus" id="P19235"/>
<dbReference type="BioMuta" id="EPOR"/>
<dbReference type="DMDM" id="119524"/>
<dbReference type="MassIVE" id="P19235"/>
<dbReference type="PaxDb" id="P19235"/>
<dbReference type="PeptideAtlas" id="P19235"/>
<dbReference type="PRIDE" id="P19235"/>
<dbReference type="ProteomicsDB" id="53638">
<molecule id="P19235-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53639">
<molecule id="P19235-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53640">
<molecule id="P19235-3"/>
</dbReference>
<dbReference type="TopDownProteomics" id="P19235-3">
<molecule id="P19235-3"/>
</dbReference>
<dbReference type="ABCD" id="P19235">
<property type="antibodies" value="4 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="13130">
<property type="antibodies" value="879 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000222139">
<molecule id="P19235-1"/>
<property type="protein sequence ID" value="ENSP00000222139"/>
<property type="gene ID" value="ENSG00000187266"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000592375">
<molecule id="P19235-3"/>
<property type="protein sequence ID" value="ENSP00000467809"/>
<property type="gene ID" value="ENSG00000187266"/>
</dbReference>
<dbReference type="GeneID" id="2057"/>
<dbReference type="KEGG" id="hsa:2057"/>
<dbReference type="UCSC" id="uc002mrj.3">
<molecule id="P19235-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2057"/>
<dbReference type="DisGeNET" id="2057"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000187266.13"/>
<dbReference type="GeneCards" id="EPOR"/>
<dbReference type="GeneReviews" id="EPOR"/>
<dbReference type="HGNC" id="HGNC:3416">
<property type="gene designation" value="EPOR"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000187266">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="EPOR"/>
<dbReference type="MIM" id="133100">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="133171">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P19235"/>
<dbReference type="OpenTargets" id="ENSG00000187266"/>
<dbReference type="Orphanet" id="90042">
<property type="disease" value="Primary familial polycythemia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA27834"/>
<dbReference type="eggNOG" id="ENOG502RYHW">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000160315"/>
<dbReference type="HOGENOM" id="CLU_041434_0_0_1"/>
<dbReference type="InParanoid" id="P19235"/>
<dbReference type="KO" id="K05079"/>
<dbReference type="OMA" id="VGSEHAQ"/>
<dbReference type="OrthoDB" id="1442632at2759"/>
<dbReference type="PhylomeDB" id="P19235"/>
<dbReference type="TreeFam" id="TF336573"/>
<dbReference type="PathwayCommons" id="P19235"/>
<dbReference type="Reactome" id="R-HSA-9006335">
<property type="pathway name" value="Signaling by Erythropoietin"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9027276">
<property type="pathway name" value="Erythropoietin activates Phosphoinositide-3-kinase (PI3K)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9027277">
<property type="pathway name" value="Erythropoietin activates Phospholipase C gamma (PLCG)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9027283">
<property type="pathway name" value="Erythropoietin activates STAT5"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9027284">
<property type="pathway name" value="Erythropoietin activates RAS"/>
</dbReference>
<dbReference type="SignaLink" id="P19235"/>
<dbReference type="SIGNOR" id="P19235"/>
<dbReference type="BioGRID-ORCS" id="2057">
<property type="hits" value="7 hits in 872 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="EPOR">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P19235"/>
<dbReference type="GeneWiki" id="Erythropoietin_receptor"/>
<dbReference type="GenomeRNAi" id="2057"/>
<dbReference type="Pharos" id="P19235">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P19235"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="P19235">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000187266">
<property type="expression patterns" value="Expressed in type B pancreatic cell and 237 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P19235">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P19235">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0004900">
<property type="term" value="F:erythropoietin receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0007420">
<property type="term" value="P:brain development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046697">
<property type="term" value="P:decidualization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014068">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046579">
<property type="term" value="P:positive regulation of Ras protein signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="CDD" id="cd00063">
<property type="entry name" value="FN3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR009167">
<property type="entry name" value="Erythropoietin_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003961">
<property type="entry name" value="FN3_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036116">
<property type="entry name" value="FN3_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR015152">
<property type="entry name" value="Growth/epo_recpt_lig-bind"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003528">
<property type="entry name" value="Long_hematopoietin_rcpt_CS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR23037:SF28">
<property type="entry name" value="PTHR23037:SF28"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09067">
<property type="entry name" value="EpoR_lig-bind"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00041">
<property type="entry name" value="fn3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF001959">
<property type="entry name" value="EPO_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00060">
<property type="entry name" value="FN3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49265">
<property type="entry name" value="SSF49265"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50853">
<property type="entry name" value="FN3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS01352">
<property type="entry name" value="HEMATOPO_REC_L_F1"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0985">Congenital erythrocytosis</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide">
<location>
<begin position="1"/>
<end position="24"/>
</location>
</feature>
<feature type="chain" description="Erythropoietin receptor" id="PRO_0000010868">
<location>
<begin position="25"/>
<end position="508"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="11">
<location>
<begin position="25"/>
<end position="250"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="11">
<location>
<begin position="251"/>
<end position="273"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="11">
<location>
<begin position="274"/>
<end position="508"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III" evidence="12">
<location>
<begin position="147"/>
<end position="247"/>
</location>
</feature>
<feature type="region of interest" description="Required for high-affinity SOCS3 binding">
<location>
<begin position="454"/>
<end position="456"/>
</location>
</feature>
<feature type="short sequence motif" description="WSXWS motif">
<location>
<begin position="233"/>
<end position="237"/>
</location>
</feature>
<feature type="short sequence motif" description="Box 1 motif">
<location>
<begin position="282"/>
<end position="290"/>
</location>
</feature>
<feature type="short sequence motif" description="ITIM motif">
<location>
<begin position="452"/>
<end position="457"/>
</location>
</feature>
<feature type="site" description="Required for ligand binding">
<location>
<position position="117"/>
</location>
</feature>
<feature type="site" description="Interaction with APS and STAT5, and activation" evidence="9">
<location>
<position position="368"/>
</location>
</feature>
<feature type="site" description="Required for STAT5/PTPN11/SOCS3 binding" evidence="9">
<location>
<position position="426"/>
</location>
</feature>
<feature type="site" description="Interaction with PTPN6" evidence="9">
<location>
<position position="454"/>
</location>
</feature>
<feature type="site" description="Required for STAT1/STAT3 activation">
<location>
<position position="456"/>
</location>
</feature>
<feature type="site" description="Required for CrkL binding" evidence="9">
<location>
<position position="485"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by JAK2" evidence="10">
<location>
<position position="368"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by JAK2" evidence="10">
<location>
<position position="426"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by JAK2" evidence="10">
<location>
<position position="454"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by JAK2" evidence="10">
<location>
<position position="456"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by JAK2" evidence="10">
<location>
<position position="468"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by JAK2" evidence="10">
<location>
<position position="485"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by JAK2" evidence="10">
<location>
<position position="489"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by JAK2" evidence="10">
<location>
<position position="504"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="11">
<location>
<position position="76"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="52"/>
<end position="62"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="91"/>
<end position="107"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="10">
<location>
<position position="281"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="10">
<location>
<position position="453"/>
</location>
</feature>
<feature type="splice variant" description="In isoform EPOR-S." id="VSP_009508" evidence="28">
<original>VEILEGRTECVLSNLRGRTRYTFAVRARMAEPSFGGFWSAWSEPVS</original>
<variation>GTVFLSPDWLSSTRARPHVIYFCLLRVPRPDSAPRWRSWRAAPSVC</variation>
<location>
<begin position="196"/>
<end position="241"/>
</location>
</feature>
<feature type="splice variant" description="In isoform EPOR-S." id="VSP_009509" evidence="28">
<location>
<begin position="242"/>
<end position="508"/>
</location>
</feature>
<feature type="splice variant" description="In isoform EPOR-T." id="VSP_009510" evidence="28">
<original>LWLYQNDGCLWWSPCTPFTEDPP</original>
<variation>VGGLVVPSVPGLPCFLQPNCRPL</variation>
<location>
<begin position="306"/>
<end position="328"/>
</location>
</feature>
<feature type="splice variant" description="In isoform EPOR-T." id="VSP_009511" evidence="28">
<location>
<begin position="329"/>
<end position="508"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35423344." id="VAR_033919">
<original>P</original>
<variation>A</variation>
<location>
<position position="380"/>
</location>
</feature>
<feature type="sequence variant" description="In ECYT1 and erythroleukemia; dbSNP:rs62638745." id="VAR_027372" evidence="25">
<original>N</original>
<variation>S</variation>
<location>
<position position="487"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs142094773." id="VAR_027373" evidence="21 23">
<original>P</original>
<variation>S</variation>
<location>
<position position="488"/>
</location>
</feature>
<feature type="mutagenesis site" description="Little effect on EPO binding." evidence="26">
<original>T</original>
<variation>A</variation>
<location>
<position position="114"/>
</location>
</feature>
<feature type="mutagenesis site" description="Little effect on EPO binding." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="115"/>
</location>
</feature>
<feature type="mutagenesis site" description="10-fold reduction in EPO binding." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="116"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced EPO binding." evidence="26">
<original>F</original>
<variation>A</variation>
<variation>L</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="mutagenesis site" description="60-fold reduction in EPO binding." evidence="26">
<original>F</original>
<variation>W</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="mutagenesis site" description="8-fold reduction in EPO binding." evidence="26">
<original>F</original>
<variation>Y</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="mutagenesis site" description="16-fold reduction in EPO binding." evidence="26">
<original>V</original>
<variation>A</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="mutagenesis site" description="Some reduction in EPO binding." evidence="26">
<original>L</original>
<variation>A</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="mutagenesis site" description="Little effect on EPO binding." evidence="26">
<original>E</original>
<variation>A</variation>
<location>
<position position="121"/>
</location>
</feature>
<feature type="mutagenesis site" description="Little effect on EPO binding." evidence="26">
<original>R</original>
<variation>A</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="mutagenesis site" description="Little effect on EPO binding." evidence="26">
<original>M</original>
<variation>A</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="mutagenesis site" description="16-fold reduction in EPO binding." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="mutagenesis site" description="Little effect on EPO binding." evidence="26">
<original>H</original>
<variation>A</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="mutagenesis site" description="Little effect on EPO binding." evidence="26">
<original>R</original>
<variation>A</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="mutagenesis site" description="Some loss of SOCS3 binding." evidence="18">
<original>Y</original>
<variation>F</variation>
<location>
<position position="454"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibition of STAT1/STAT3 activity. No effect on STAT5 activity. Some loss of SOCS3 binding." evidence="16 18">
<original>Y</original>
<variation>F</variation>
<location>
<position position="456"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on STAT1/STAT3 nor STAT5 activity." evidence="16">
<original>Y</original>
<variation>F</variation>
<location>
<position position="468"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; no nucleotide entry." ref="1" evidence="29">
<original>A</original>
<variation>R</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; no nucleotide entry." ref="1" evidence="29">
<original>GA</original>
<variation>RP</variation>
<location>
<begin position="189"/>
<end position="190"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; no nucleotide entry." ref="1" evidence="29">
<original>T</original>
<variation>E</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="33"/>
<end position="45"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="47"/>
<end position="49"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="51"/>
<end position="58"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="61"/>
<end position="67"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="76"/>
<end position="83"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="84"/>
<end position="86"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="89"/>
<end position="91"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="93"/>
<end position="98"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="99"/>
<end position="101"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="102"/>
<end position="108"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="111"/>
<end position="113"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="116"/>
<end position="118"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="120"/>
<end position="126"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="127"/>
<end position="129"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="131"/>
<end position="137"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="139"/>
<end position="141"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="142"/>
<end position="144"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="149"/>
<end position="155"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="157"/>
<end position="160"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="162"/>
<end position="167"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="169"/>
<end position="171"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="175"/>
<end position="177"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="178"/>
<end position="185"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="188"/>
<end position="190"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="195"/>
<end position="198"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="204"/>
<end position="207"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="212"/>
<end position="224"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="226"/>
<end position="228"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="240"/>
<end position="244"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="245"/>
<end position="247"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="250"/>
<end position="282"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="289"/>
<end position="293"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="294"/>
<end position="299"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="304"/>
<end position="311"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="316"/>
<end position="320"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1CN4"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1EER"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1ERN"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2MV6"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4Y5Y"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6E2Q"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6MOF"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6MOJ"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250"/>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P14753"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255"/>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00316"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10374881"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10388848"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11722595"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11756159"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11784712"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12027890"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12746455"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25092874"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27535533"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7534299"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8174675"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8506290"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8608241"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8662939"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9774108"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1324524"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000305"/>
<sequence length="508" mass="55065" checksum="F9F326E162E9512A" modified="1990-11-01" version="1" precursor="true">MDHLGASLWPQVGSLCLLLAGAAWAPPPNLPDPKFESKAALLAARGPEELLCFTERLEDLVCFWEEAASAGVGPGNYSFSYQLEDEPWKLCRLHQAPTARGAVRFWCSLPTADTSSFVPLELRVTAASGAPRYHRVIHINEVVLLDAPVGLVARLADESGHVVLRWLPPPETPMTSHIRYEVDVSAGNGAGSVQRVEILEGRTECVLSNLRGRTRYTFAVRARMAEPSFGGFWSAWSEPVSLLTPSDLDPLILTLSLILVVILVLLTVLALLSHRRALKQKIWPGIPSPESEFEGLFTTHKGNFQLWLYQNDGCLWWSPCTPFTEDPPASLEVLSERCWGTMQAVEPGTDDEGPLLEPVGSEHAQDTYLVLDKWLLPRNPPSEDLPGPGGSVDIVAMDEGSEASSCSSALASKPSPEGASAASFEYTILDPSSQLLRPWTLCPELPPTPPHLKYLYLVVSDSGISTDYSSGDSQGAQGGLSDGPYSNPYENSLIPAAEPLPPSYVACS</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

